QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 docgo-plans-to-roll-out-longitudinal-care-services-in-q4-in-collaboration-with-california-based-insurance-provider

DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health an...

 docgo-acquires-virtual-care-platform-steadymd-no-financial-terms-disclosed-in-2025-steadymd-is-expected-to-generate-25m-in-revenue-and-is-expected-to-be-ebitda-positive-for-2026

Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform...

 canaccord-genuity-maintains-hold-on-docgo-raises-price-target-to-16

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and raises the price target from $1.45 to ...

 docgo-affirms-fy2025-sales-guidance-of-300000m-330000m-vs-314472m-est

DocGo (NASDAQ:DCGO) affirms FY2025 sales outlook from $300.000 million-$330.000 million to $300.000 million-$330.000 million vs...

 docgo-q2-eps-011-misses-009-estimate-sales-80418m-beat-77569m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 17...

 docgo-extends-share-repurchase-program-to-december-31-2025

-SEC Filing

 canaccord-genuity-downgrades-docgo-to-hold-lowers-price-target-to-145

Canaccord Genuity analyst Richard Close downgrades DocGo (NASDAQ:DCGO) from Buy to Hold and lowers the price target from $5 ...

 needham-maintains-buy-on-docgo-lowers-price-target-to-3

Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $3.

 docgo-lowers-fy2025-sales-guidance-from-41000m-45000m-to-30000m-33000m

DocGo (NASDAQ:DCGO) lowers FY2025 sales outlook from $410.00 million-$450.00 million to $300.00 million-$330.00 million.

 docgo-q1-eps-009-misses-002-estimate-sales-9603m-miss-10425m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.02) by 35...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION